Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Health Catalyst, Inc. (HCAT : NSDQ)
 
 • Company Description   
Health Catalyst Inc. is a provider of data and analytics technology and services to healthcare organizations. Health Catalyst Inc. is based in Salt Lake City, Utah.

Number of Employees: 1,500

 
 • Price / Volume Information   
Yesterday's Closing Price: $4.06 Daily Weekly Monthly
20 Day Moving Average: 542,381 shares
Shares Outstanding: 69.60 (millions)
Market Capitalization: $282.58 (millions)
Beta: 1.51
52 Week High: $9.24
52 Week Low: $3.49
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -0.98% -5.38%
12 Week 3.31% -11.76%
Year To Date -42.57% -46.21%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
10897 SOUTH RIVER FRONT PARKWAY #300
-
SOUTH JORDAN,UT 84095
USA
ph: 801-708-6800
fax: -
ir@healthcatalyst.com http://www.healthcatalyst.com
 
 • General Corporate Information   
Officers
Daniel Burton - Chief Executive Officer and Director
Jason Alger - Chief Financial Officer
John A. Kane - Director
Duncan Gallagher - Director
Jill Hoggard Green - Director

Peer Information
Health Catalyst, Inc. (HLIS)
Health Catalyst, Inc. (AZTA)
Health Catalyst, Inc. (APYI)
Health Catalyst, Inc. (RNVA)
Health Catalyst, Inc. (HMSY)
Health Catalyst, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 42225T107
SIC: 7370
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/06/25
Share - Related Items
Shares Outstanding: 69.60
Most Recent Split Date: (:1)
Beta: 1.51
Market Capitalization: $282.58 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.04 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.22 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 5.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/06/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.76
Price/Cash Flow: 11.52
Price / Sales: 0.91
EPS Growth
vs. Year Ago Period: 28.57%
vs. Previous Quarter: 23.08%
Sales Growth
vs. Year Ago Period: 6.28%
vs. Previous Quarter: -0.24%
ROE
06/30/25 - -
03/31/25 - -6.14
12/31/24 - -6.48
ROA
06/30/25 - -
03/31/25 - -2.74
12/31/24 - -3.04
Current Ratio
06/30/25 - -
03/31/25 - 1.24
12/31/24 - 1.43
Quick Ratio
06/30/25 - -
03/31/25 - 1.24
12/31/24 - 1.43
Operating Margin
06/30/25 - -
03/31/25 - -7.17
12/31/24 - -7.58
Net Margin
06/30/25 - -
03/31/25 - -23.34
12/31/24 - -22.67
Pre-Tax Margin
06/30/25 - -
03/31/25 - -23.20
12/31/24 - -22.56
Book Value
06/30/25 - -
03/31/25 - 5.37
12/31/24 - 6.00
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.40
12/31/24 - 0.41
Debt-to-Capital
06/30/25 - -
03/31/25 - 28.65
12/31/24 - 29.28
 

Powered by Zacks Investment Research ©